# Vitalant – FDA Inspection, Apr 17, 2013

Source: https://www.keypedia.com/records/fda_inspections/vitalant/6bc4d130-cbae-4b39-9675-c883d9cba194
Source feed: FDA_Inspections

> FDA inspection 828029 of Vitalant, April 17, 2013. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 606. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 828029
- Company Name: Vitalant
- Inspection Date: 2013-04-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1256346 - 2024-11-13
- FDA Inspection 1098186 - 2019-06-24
- FDA Inspection 1009750 - 2017-05-03
- FDA Inspection 925827 - 2015-05-11
- [FDA Inspection 744380 - 2011-09-07](https://www.keypedia.com/records/fda_inspections/vitalant/09b96969-d32c-48e7-a56a-af4c4efcebd0)

Company: https://www.keypedia.com/companies/vitalant/be9f6ee8-7471-4a32-896a-426ed550e7f6

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d